Bone Cell Biology Osteoblasts, Osteocytes, and Osteoclasts

Pediatric Bone: Biology & Diseases

Volumn , Issue , 2003, Pages 43-75

  Aubin, Jane E ^a   Heersche, Johan N M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902758808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012286551-0/50004-X     Document Type: Chapter

References (348)

1. Parfitt A.M. Targeted and nontargeted bone remodeling: Relationship to basic multicellular unit origination and progression. Bone 2002, 30:5-7.
2. Manolagas S.C. Birth and death of bone cells: Basic regula-tory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000, 21:115-137.
3. Hock J.M., Krishnan V., Onyia J.E., Bidwell J.P., Milas J., Stanislaus D. Osteoblast apoptosis and bone turnover. J.Bone Miner. Res. 2001, 16:975-984.
4. Parfitt A.M. The bone remodeling compartment: A circulatory function for bone lining cells. J.Bone Miner. Res. 2001, 16:1583-1585.
5. Waller E.K., Olweus J., Lund-Johansen F., Huang S., Nguyen M., Guo G.R., Terstappen L. The "common stem cell" hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 1995, 85:2422-2435.
6. Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 1982, 34:285-290.
7. Heersche J.N.M., Manolson M. The role of osteo-clasts in bone. The Osteoporosis Primer 2000, 36-45. Cambridge Univ. Press, New York. J.E. Henderson, D. Goltzman (Eds.).
8. Baron R., Neff L., Louvard D., Courtoy P.J. Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane prot. J.Cell Biol. 1985, 101:2210-2222.
9. Tezuka K., Nemoto K., Tezuka Y., Sato T., Ikeda Y., Kobori M., Kawashima H., Eguchi H., Hakeda Y., Kumegawa M. Identification of matrix metalloproteinase 9 in rabbit osteo-clasts. J.Biol Chem. 1994, 269:15006-15009.
10. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J.Biol. Chem. 1996, 271:12511-12516.
11. Parfitt A.M. The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif. Tissue Int. 1984, 36:S37-S45.
12. Tran Van P., Vignery A., Baron R. An electron-microscopic study of the bone-remodeling sequence in the rat. Cell Tissue Res. 1982, 225:283-292.
13. Tran Van P.T., Vignery A., Baron R. Cellular kinetics of the bone remodeling sequence in the rat. Anat. Rec. 1982, 202:445-451.
14. Aubin J.E., Triffitt J. Mesenchymal stem cells and the osteoblast lineage. Principles of Bone Biology 2002, 59-81. Academic Press, Cambridge, UK. 2nd ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
15. Aubin J.E. Bone stem cells. 25th anniversary issue: New directions and dimensions in cellular biochemistry Invited chapter. J.Cell. Biochem. Suppl. 1998, 30/31:73-82.
16. Friedenstein A.J. Osteogenic stem cells in the bone marrow. Bone and Mineral Research/7 1990, 243-270. Elsevier, New York. J.N.M. Heersche, J.A. Kanis (Eds.).
17. Owen M.E. The marrow stromal cell system. Marrow Stromal Stem Cells in Culture 1998, 88-110. Cambridge Univ. Press, New York. J.N. Beresford, M.E. Owen (Eds.).
18. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
19. Bianco P., Riminucci M., Kuznetsov S., Robey P.G. Multipotential cells in the bone marrow stroma: Regulation in the context of organ physiology. Crit. Rev. Eukaryot. Gene Expr. 1999, 9:159-173.
20. Morrison S.J., Shah N.M., Anderson D.J. Regulatory mechanisms in stem cell biology. Cell 1997, 88:287-298.
21. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:141-147.
22. Friedenstein A.J. Stromal mechanisms of bone marrow: Cloning in vitro and retransplantation in vivo. Hamatol. Bluttrans-fus. 1980, 25:19-29.
23. Kuznetsov S.A., Krebsbach P.H., Satomura K., Kerr J., Riminucci M., Benayahu D., Robey P.G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J.Bone Miner. Res. 1997, 12:1335-1347.
24. Aubin J.E. Osteoprogenitor cell frequency in rat bone marrow stromal cell populations: Role for heterotypic cell-cell interactions in osteoblast differentiation. J.Cell. Biochem. 1999, 72:396-410.
25. Wu X., Peters J.M., Gonzalez F.J., Prasad H.S., Rohrer M.D., Gimble J.M. Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-alpha-null mice. Bone 2000, 26:21-26.
26. Poliard A., Nifuji A., Lamblin D., Plee E., Forest C., Kellerman O. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogemic, chondrogenic or adipogenicpathways. J.Cell Biol. 1995, 130:1461-1472.
27. Aubin J.E., Heersche J.M.N. Vitamin D and osteoblasts. Vitamin D 1997, 313-328. Academic Press, Cambridge, UK. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
28. Nuttall M.E., Gimble J.M. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis. Bone 2000, 27:177-184.
29. Bellows C.G., Heersche J.N. The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria. J.Bone Miner. Res. 2001, 16:1983-1993.
30. Gimble J.M., Robinson C.E., Kelly K.A. The function of adipocytes in the bone marrow stroma: An update. Bone 1996, 19:421-428.
31. Rickard D.J., Kassem M., Hefferan T.E., Sarkar G., Spelsberg T.C., Riggs B.L. Isolation and characterization of osteoblast precursor cells from human bone marrow. J.Bone Miner. Res. 1996, 11:312-324.
32. Nuttall M.E., Patton A.J., Olivera D.L., Nadeau D.P., Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteogenic disorders. J.Bone Miner. Res. 1998, 13:371-382.
33. Vescovi A.L., Snyder E.Y. Establishment and properties of neural stem cell clones: Plasticity in vitro and in vivo. Brain Pathol. 1999, 9:569-598.
34. Williams J.H., Klinken S.P. Plasticity in the haemo-poietic system. Int. J. Biochem. Cell. Biol. 1999, 31:1237-1242.
35. Hole N. Embryonic stem cell-derived haematopoiesis. Cells Tissues Organs 1999, 165:181-189.
36. Bianco P., Cossu G. Uno, nessuno e centomila: Searching for the identity of mesodermal progenitors. Exp. Cell Res. 1999, 251:257-263.
37. Seale P., Rudnicki M.A. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 2000, 218:115-124.
38. Hodge C.J., Boakye M. Biological plasticity: The future of science in neurosurgery. Neurosurgery 2001, 48:2-16.
39. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 1999, 96:10711-10716.
40. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J.Neurosci. Res. 2000, 61:364-370.
41. Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Man-ira A., Prockop D.J., Olson L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. USA 2002, 99:2199-2204.
42. Hirschi K.K., Goodell M.A. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther. 2002, 9:648-652.
43. Wagers A.J., Christensen J.L., Weissman I.L. Cell fate determination from stem cells. Gene Ther. 2002, 9:606-612.
44. Orkin S.H., Zon L.I. Hematopoiesis and stem cells: Plasticity versus developmental heterogeneity. Nat. Immunol. 2002, 3:323-328.
45. Ying Q.L., Nichols J., Evans E.P., Smith A.G. Changing potency by spontaneous fusion. Nature 2002, 416:545-548.
46. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416:542-545.
47. Wurmser A.E., Gage F.H. Stem cells: Cell fusion causes confusion. Nature 2002, 416:485-487.
48. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001, 98:2615-2625.
49. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
50. Eaves C., Miller C., Conneally E., Audet J., Oostendorp R., Cashman J., Zandstra P., Rose-John S., Piret J., Eaves A. Introduction to stem cell biology in vitro. Threshold to the future. Ann. N. Y. Acad. Sci. 1999, 872:1-8.
51. Huss R., Lange C., Weissinger E.M., Kolb H.J., Thalmeier K. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 2000, 18:252-260.
52. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J.Cell Biol. 2001, 153:1133-1140.
53. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000, 109:235-242.
54. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellan-Tuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
55. Asakura A., Komaki M., Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
56. Gronthos S., Franklin D.M., Leddy H.A., Robey P.G., Storms R.W., Gimble J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J.Cell. Physiol. 2001, 189:54-63.
57. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
58. Huang J.I., Beanes S.R., Zhu M., Lorenz H.P., Hedrick M.H., Benhaim P. Rat extramedullary adipose tissue as a source of osteochondrogenic progenitor cells. Plastic Reconstr. Surg. 2002, 109:1033-1041.
59. Perry R.L., Rudnicki M.A. Molecular mechanisms regulating myogenic determination and differentiation. Frontiers Biosci. 2000, 5:D750-D767.
60. Rosen E.D., Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell. Dev. Biol. 2000, 16:145-171.
61. Bi W., Deng J.M., Zhang Z., Behringer R.R., De Crom-Brugghe B. Sox9 is required for cartilage formation. Nature Genet. 1999, 22:85-89.
62. De Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000, 19:389-394.
63. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002, 2:389-406.
64. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfal: A transcriptional activator of osteoblast dif-ferentiation. Cell 1997, 89:747-754.
65. Banerjee C., Mccabe L., Choi J.-Y., Hiebert S.W., Stein J.L., Stein G.S., Lian J.B. Runt homology domain proteins in osteoblast differentiation: AML-3 is a major component of a bone specific complex. J.Cell. Biochem. 1997, 66:1-8.
66. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764. [see Comments].
67. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geof-Froy V., Amling M., Karsenty G. A Cbfal-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13:1025-1036.
68. Karsenty G. The genetic transformation of bone biology. Genes Dev. 1999, 13:3037-3051.
69. Ducy P. CBFA1: A molecular switch in osteoblast biology. Dev. Dyn. 2000, 219:461-471.
70. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfal. Endocr. Rev. 2000, 21:393-411.
71. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., Rosen V., Stein J.L., Van Wijnen A.J., Stein G.S., Lian J.B., Ryoo H.M. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor betal in C2C12 myogenic cells coincides with suppre. J.Cell. Biochem. 1999, 73:114-125.
72. Wang D., Christensen K., Chawla K., Xiao G., Krebsbach P.H., Franceschi R.T. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J.Bone Miner. Res. 1999, 14:893-903.
73. Liu W., Toyosawa S., Furuichi T., Kanatani N., Yoshida C., Liu Y., Himeno M., Narai S., Yamaguchi A., Komori T. Overexpression of Cbfal in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J.Cell. Biol. 2001, 155:157-166.
74. Inada M., Yasui T., Nomura S., Miyake S., Deguchi K., Himeno M., Sato M., Yamagiwa H., Kimura T., Yasui N., Ochi T., Endo N., Kitamura Y., Kishimoto T., Komori T. Maturational disturbance of chondrocytes in Cbfal -deficient mice. Dev. Dyn. 1999, 214:279-290.
75. Kim I.S., Otto F., Zabel B., Mundlos S. Regulation of chondrocyte differentiation by Cbfal. Mech. Dev. 1999, 80:159-170.
76. Enomoto H., Enomoto-Iwamoto M., Iwamoto M., Nomura S., Himeno M., Kitamura Y., Kishimoto T., Komori T. Cbfal is a positive regulatory factor in chondrocyte maturation. J.Biol. Chem. 2000, 275:8695-8702.
77. Komori T. A fundamental transcription factor for bone and cartilage. Biochem. Biophys. Res. Commun. 2000, 276:813-816.
78. Lecka-Czernik B., Gubrij I., Moerman E.J., Kajkenova O., Lipschitz D.A., Manolagas S.C., Jilka R.L. Inhibition of Osf2/Cbfal expression and terminal osteoblast differentiation by PPARgamma2. J.Cell. Biochem. 1999, 74:357-371.
79. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., De Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
80. St.-Jacques B., Hammerschmidt M., Mcmahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999, 13(19):2617. published erratum appears.
81. Genes Dev. 1999 Oct 1, 13:2072-2086.
82. Chuang P.T., McMahon A.P. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999, 397:617-621.
83. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D., Boyle W.J., Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J.Bone Miner. Res. 2000, 15:2-12.
84. Eipers P.G., Kale S., Taichman R.S., Pipia G.G., Swords N.A., Mann K.G., Long M.W. Bone marrow accessory cells regulate human bone precursor cell development. Exp. Hematol. 2000, 28:815-825.
85. Herzenberg L.A., De Rosa S.C. Monoclonal antibodies and the FACS: Complementary tools for immunobiology and medicine. Immunol Today 2000, 21:383-390.
86. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
87. Bruder S.P., Horowitz M.C., Mosca J.D., Haynesworth S.E. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997, 21:223-235.
88. Bruder S.P., Ricalton N.S., Boynton R.E., Connolly T.J., Jaiswal N., Zaia J., Barry F.P. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J.Bone Miner. Res. 1998, 13:655-663.
89. Joyner C.J., Bennett A., Triffitt J.T. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 1997, 21:1-6.
90. Gronthos S., Graves S.E., Ohta S., Simmons P.J. The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
91. Bowen M.A., Aruffo A.A., Bajorath J. Cell surface receptors and their ligands: In vitro analysis of CD6-CD166 interactions. Proteins 2000, 40:420-428.
92. Bowen M.A., Aruffo A. Adhesion molecules, their receptors, and their regulation: Analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions. Transplant Proc. 1999, 31:795-796.
93. Nelissen J.M., Torensma R., Pluyter M., Adema G.J., Raymakers R.A., Van Kooyk Y., Figdor C.G. Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS. Exp. Hematol. 2000, 28:422-432.
94. Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD 105). Biochem. Biophys. Res. Commun. 1999, 265:134-139.
95. Fleming J.E.J., Haynesworth S.E., Cassiede P., Baber M.A., Caplan A.I. Monoclonal antibody against adult marrow-derived mesenchymal stem cells recognizes developing vasculature in embryonic human skin. Dev. Dyn. 1998, 212:119-132.
96. Oreffo R.O.C., Virdi A.S., Triffitt J.T. Retroviral marking of human bone marrow fibroblasts: In vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo. J.Cell. Physiol. 2001, 186:201-209.
97. Gronthos S., Zannettino A.C.W., Hay S.J., Shi S., Graves S.E., Kortesidis A., Simmons P.J. Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J.Cell Sci. 2003, 116:1827-1835.
98. Aubin J.E., Turksen K. Monoclonal antibodies as tools for studying the osteoblast lineage. Microsc. Res. Technique. 1996, 33:128-140.
99. Gronthos S., Zannettino A.C., Graves S.E., Ohta S., Hay S.J., Simmons P.J. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J.Bone Miner. Res. 1999, 14:47-56.
100. Stewart K., Walsh S., Screen J., Jefferiss C.M., Chainey J., Jordan G.R., Beresford J.N. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J.Bone Miner. Res. 1999, 14:1345-1356.
101. Van Vlasselaer P., Falla N., Snoeck H., Mathieu E. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sea-1 monoclonal antibody and wheat germ ag. Blood 1994, 84:753-763.
102. Zohar R., Sodek J., Mcculloch C.A. Characterization of stromal progenitor cells enriched by flow cytometry. Blood 1997, 90:3471-3481.
103. Zohar R., Mcculloch C.A., Sampath K., Sodek J. Flow cytometric analysis of recombinant human osteogenic protein-1 (BMP-7) responsive subpopulations from fetal rat calvaria based on intracellular osteoponti. Matrix Biol. 1998, 16:295-306.
104. Aubin J.E., Liu F. The osteoblast lineage. Principles of Bone Biology 1996, 51-67. Academic Press, San Diego. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
105. Dacic S., Kalajzic I., Visnjic D., Lichtler A.C., Rowe D.W. Collal-driven transgenic markers of osteoblast lineage progression. J.Bone Miner. Res. 2001, 16:1228-1236.
106. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., Rowe D. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J.Bone Miner. Res. 2002, 17:15-25.
107. Rowe D., Lichtler A. A strategy for identifying osteoporosis risk genes. Endocrine 2002, 17:67-75.
108. Herbertson A., Aubin J. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J.Bone Miner. Res. 1995, 10:285-294.
109. Herbertson A., Aubin J.E. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. Bone 1997, 21:491-500.
110. Bellows C.G., Aubin J.E. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev. Biol. 1989, 133:8-13.
111. Falla N., Van Vlassalaer P., Bierkens J., Borremans B., Schoeters G., Van Gorp U. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 1993, 82:3580-3591.
112. Lomri A., Marie P.J., Tran P.V., Hott M., Onyia J.E., Hale L.V., Miles R.R., Cain R.L., Tu Y., Hulman J.F., Hock J.M., Santerre R.F. Characterization of endosteal osteoblas-tic cells isolated from mouse caudal vertebrae. Bone 1988, 9:165-175.
113. Ishida Y., Bellows C.G., Tertinegg I., Heersche J.N. Progesterone-mediated stimulation of osteoprogenitor proliferation and differentiation in cell populations derived from adult or fetal rat bone tissue depends. Osteoporos Int. 1997, 7:323-330.
114. Onyia J.E., Miller B., Hulman J., Liang J., Galvin R., Frolik C., Chandrasekhar S., Harvey A.K., Bidwell J., Herring J., Hock J.M., Hale L.V., Miles R.R., Cain R.L., Tu Y., Hulman J.F., Santerre R.F. Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone 1997, 20:93-100.
115. Turksen K., Aubin J.E. Positive and negative immu-noselection for enrichment of two classes of osteoprogenitor cells. J.Cell Biol. 1991, 114:373-384.
116. Bellows C.G., Aubin J.E., Heersche J.N.M. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 1987, 121:1985-1992.
117. Ishida Y., Heersche J.N. Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male. Bone 1997, 20:17-25.
118. Hughes F.J., Collyer J., Stanfield M., Goodman S.A. The effects of bone morphogenetic protein-2, -4 and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995, 136:2671-2677.
119. Scutt A., Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow st. Calcif. Tissue Int. 1999, 64:69-77.
120. Madras N., Gibbs A.L., Zhou Y., Zandstra P.W., Aubin J.E. Modeling stem cell development by retrospective analysis of gene expression profiles in single progenitor-derived colonies. Stem Cells 2002, 20:230-240.
121. Doherty M.J., Canfield A.E. Gene expression during vascular pericyte differentiation. Crit. Rev. Eukaryot. Gene Expr. 1999, 9:1-17.
122. Proudfoot D., Shanahan C.M., Weissberg P.L. Vascular calcification: New insights into an old problem. J.Pathol. 1998, 185:1-3.
123. Shanahan C.M., Proudfoot D., Tyson K.L., Cary N.R., Edmonds M., Weissberg P.L. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z.Kardiol. 2000, 89:63-68.
124. Scutt A., Bertram P. Bone marrow cells are targets for the anabolic actions of PGE2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors. J.Bone Miner. Res. 1995, 10:474-487.
125. Long M.W., Robinson J.A., Mann K.G. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J.Clin. Invest. 1995, 95:881-887.
126. Malaval L., Liu F., Roche P., Aubin J.E. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J.Cell. Biochem. 1999, 74:616-627.
127. Bellows C.G., Heersche J.N.M., Aubin J.E. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev. Biol. 1990, 140:132-138.
128. Mcculloch C.A.G., Strugurescu M., Hughes F., Melcher A.H., Aubin J.E. Osteogenic progenitor cells in rat bone marrow stromal populations exhibit self-renewal in culture. Blood 1991, 77:1906-1911.
129. Zandstra P.W., Jervis E., Haynes C.A., Kilburn D.G., Eaves C.J., Piret J.M. Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells. Biotechnol. Bioeng. 1999, 63:493-501.
130. Ramsfjell V., Bryder D., Bjorgvinsdottir H., Kornfalt S., Nils-Son L., Borge O.J., Jacobsen S.E. Distinct requirements for optimal growth and In vitro expansion of human CD34 (+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC. Blood 1999, 94:4093-4102.
131. Mechanisms Regulating Osteoblast Proliferation and Differentiation 1996, Academic Press, San Diego. G.S. Stein, J.B. Lian, J.L. Stein, A.J. van Wijnen, B. Frenkel, M. Montecino (Eds.).
132. Liu F., Aubin J.E. Identification and molecular characterization of preosteoblasts in the osteoblast differentiation sequence. J.Bone Miner. Res. 1994, 9:SI25.
133. Liu F., Malaval L., Aubin J.E. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J.Cell Sci. 2003, 116:1787-1796.
134. Candeliere G.A., Rao Y., Floh A., Sandier S.D., Aubin J.E. cDNA fingerprinting of osteoprogenitor cells to isolate differentiation stage-specific genes. Nucleic Acids Res. 1999, 27:1079-1083.
135. Aubin J.E., Candeliere G.A., Bonnelye E. Heterogeneity of the osteoblast phenotype. Endocrinologist 1999, 9:25-31.
136. Liu F., Malaval L., Gupta A., Aubin J.E. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemic. Dev. Biol. 1994, 166:220-234.
137. Malaval L., Modrowski D., Gupta A.K., Modrowski D., Gupta A.K., Aubin J.E. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J.Cell. Physiol. 1994, 158:555-572.
138. Pockwinse S.M., Stein J.L., Lian J.B., Stein G.S. Developmental stage-specific cellular responses to vitamin D3 and glucocorticoids during differentiation of the osteoblast phenotype: Interrelationships of mo. Exp. Cell Res. 1995, 216:244-260.
139. Liu F., Malaval L., Aubin J.E. The mature osteoblast phenotype is characterized by extensive palsticity. Exp. Cell Res. 1997, 232:97-105.
140. Candeliere G.A., Liu F., Aubin J.E. Individual osteoblasts in the developing calvaria express different gene repertoires. Bone 2001, 28:351-361.
141. Heersche J.N.M., Reimers S., Wrana J.L., Waye M.M.Y., Gupta A.K. Changes in expression of alpha 1 type 1 collagen and osteocalcin mRNA in osteoblasts and odontoblast-sat different stages of maturity as shown by in situ hybr. Proc. Finn. Dent. Soc. 1992, 88:173-182.
142. Bianco P., Riminucci M., Bonucci E., Termine J.D., Robey P.G. Bone sialoprotein (BSP) secretion and osteoblast differentiation: Relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. J.Histochem. Cytochem. 1993, 41:183-191.
143. Ingram R.T., Clarke B.L., Fisher L.W., Fitzpatrick L.A. Distribution of noncollagenous proteins in the matrix of adult human bone: Evidence of anatomic and functional heterogeneity. J.Bone Miner. Res. 1993, 8:1019-1029.
144. Ikeda T., Nagai Y., Yamaguchi A., Yokose S., Yoshiki S. Age-related reduction in bone matrix protein mRNA expression in rat bone tissues: Application of histomorphometry to in situ hybridization. Bone 1995, 16:17-23.
145. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., Waymire K., Narisawa S., Millan J.L., Macgregor G.R., Whyte M.P. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J.Bone Miner. Res. 1999, 14:2015-2026.
146. Wennberg C., Hessle L., Lundberg P., Mauro S., Narisawa S., Lerner U.H., Millan J.L. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J.Bone Miner. Res. 2000, 15:1879-1888.
147. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G. Increased bone formation in osteo-calcin-deficient mice. Nature 1996, 382:448-452.
148. Yoshitake H., Rittling S.R., Denhardt D.T., Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc. Natl. Acad. Sci. USA 1999, 96:8156-8160.
149. Aubin J.E., Gupta A.K., Zirngbl R., Rossant J. Knockout mice lacking bone sialoprotein expression have bone abnormalities. J.Bone Miner. Res. 1996, 11:S102.
150. Amling M., Herden S., Posl M., Hahn M., Ritzel H., Delling G. Heterogeneity of the skeleton: Comparison of the trabecular microarchitecture of the spine, the iliac crest, the femur, and the calcaneus. J.Bone Miner. Res. 1996, 11:36-45.
151. Byers R.J., Denton J., Hoyland J.A., Freemont A.J. Differential patterns of osteoblast dysfunction in trabecular bone in patients with established osteoporosis. J.Clin. Pathol. 1997, 50:760-764.
152. Riggs B.L., Khosla S., Melton L.J. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone. J.Bone Miner. Res. 1998, 13:763-773.
153. Calvi L.M., Sims N.A., Hunzelman J.L., Knight M.C., Giovannetti A., Saxton J.M., Kronenberg H.M., Baron R., Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J.Clin. Invest. 2001, 107:277-286.
154. Parisien M., Silverberg S.J., Shane E., De La Cruz L., Lindsay R., Bilezikian J.P., Dempster D.W. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J.Clin. Endocrinol. Metab. 1990, 70:930-938.
155. Petersen D.N., Tkalcevic G.T., Mansolf A.L., Rivera-Gonzalez R., Brown T.A. Identification of osteo-blast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and. J.Biol. Chem. 2000, 275:36172-36180.
156. Guo R., Quarles L.D. Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts. J.Bone Miner. Res. 1997, 12:1009-1017.
157. Ruchon A.F., Marcinkiewicz M., Siegfried G., Tenenhouse H.S., Desgroseillers L., Crine P., Boileau G. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J.Histochem. Cytochem. 1998, 46:459-468.
158. Ecarot B., Desbarats M. 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast. Endocrinology 1999, 140:1192-1199.
159. Ruchon A.F., Tenenhouse H.S., Marcinkiewicz M., Siegfried G., Aubin J.E., Desgroseillers L., Crine P., Boileau G. Developmental expression and tissue distribution of phex protein: Effect of the Hyp mutation and relationship to bone markers. J.Bone Miner. Res. 2000, 15:1440-1450.
160. Aubin J.E., Gupta A.K., Bhargava U., Turksen K. Expression and regulation of galectin 3 in rat osteoblastic cells. J.Cell. Physiol. 1996, 169:468-480.
161. Jamal H.H., Aubin J.E. CD44 expression in fetal rat bone: In vivo and in vitro analysis. Exp. Cell Res. 1996, 223:467-477.
162. Choi J.Y., Van Wijnen A.J., Aslam F., Leszyk J.D., Stein J.L., Stein G.S., Lian J.B., Penman S. Developmental association of the beta-galactoside-binding protein galectin-1 with the nuclear matrix of rat calvarial osteoblasts. J.Cell Sci. 1998, 111:3035-3043.
163. Hsu D.K., Yang R.Y., Pan Z., Yu L., Salomon D.R., Fung-Leung W.P., Liu F.T. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 2000, 156:1073-1083.
164. Colnot C., Sidhu S.S., Balmain N., Poirier F. Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones. Dev. Biol. 2001, 229:203-214.
165. Carulli J.P., Artinger M., Swain P.M., Root C.D., Chee L., Tulig C., Guerin J., Osborne M., Stein G., Lian J., Lomedico P.T. High throughput analysis of differential gene expression. J.Cell. Biochem. Suppl. 1998, 30/31:286-296.
166. Seth A., Lee B.K., Qi S., Vary C.P. Coordinate expression of novel genes during osteoblast differentiation. J.Bone Miner. Res. 2000, 15:1683-1696.
167. Raouf A., Seth A. Discovery of osteoblast-associated genes using cDNA microarrays. Bone 2002, 30:463-471.
168. Beck G.R., Zerler B., Moran E. Gene array analysis of osteoblast differentiation. Cell Growth Differ. 2001, 12:61-83.
169. Yoshida Y., Tanaka S., Umemori H., Minowa O., Usui M., Ikematsu N., Hosoda E., Imamura T., Kuno J., Yamashita T., Miyazono K., Noda M., Noda T., Yamamoto T. Negative regulation of BMP/Smad signaling by Tob in osteo-blasts. Cell 2000, 103:1085-1097.
170. Xiao Z.S., Hinson T.K., Quarles L.D. Cbfal isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J.Cell Biochem. 1999, 74:596-605.
171. Harada H., Tagashira S., Fujiwara M., Ogawa S., Katsumata T., Yamaguchi A., Komori T., Nakatsuka M. Cbfal isoforms exert functional differences in osteoblast differentiation. J.Biol. Chem. 1999, 274:6972-6978.
172. Drissi H., Luc Q., Shakoori R., Chuva De Sousa Lopes S., Choi J.Y., Terry A., Hu M., Jones S., Neil J.C., Lian J.B., Stein J.L., Van Wijnen A.J., Stein G.S. Transcrip-tional autoregulation of the bone related CBFA1/RUNX2 gene. J.Cell Physiol. 2000, 184:341-350.
173. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nature Genet. 2000, 24:391-395.
174. Tribioli C., Lufkin T. The murine Bapxl homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 1999, 126:5699-5711.
175. Kanzler B., Kuschert S.J., Liu Y.H., Mallo M. Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area. Development 1998, 125:2587-2597.
176. Zhou Y.X., Xu X., Chen L., Li C., Brodie S.G., Deng C.X. A Pro250Arg substitution in mouse Fgfrl causes increased expression of Cbfal and premature fusion of calvarial sutures. Hum. Mol. Genet. 2000, 9:2001-2008.
177. Hehr U., Muenke M., Masuda Y., Sasaki A., Shibuya H., Ueno N., Ikeda K., Watanabe K. Craniosynostosis syndromes: From genes to premature fusion of skull bones. Mol. Genet. Metab. 1999, 68:139-151.
178. Wilkie A.O., Tang Z., Elanko N., Walsh S., Twigg S.R., Hurst J.A., Wall S.A., Chrzanowska K.H., Maxson R.E. Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nature Genet. 2000, 24:387-390.
179. Jabs E.W., Muller U., Li X., Ma L., Luo W., Haworth I.S., Klisak I., Sparkes R., Warman M.L., Mulliken J.B., Snead M.L., Maxson R. A mutation in the home-odomain of the human Msx-2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 785:443-450.
180. Ma L., Golden S., Wu L., Maxson R., Chen Y., Zhang Y., Jiang T.X., Barlow A.J., St.Amand T.R., Hu Y., Heaney S., Francis-West P., Chuong C.M., Maas R. The molecular basis of Boston-type craniosynostosis: The Pro 148 → His mutation in the N-terminal arm of the MSX2 home-odomain stabilizes DNA binding withou. Hum. Mol. Genet. 1996, 5:1915-1920.
181. Liu Y.H., Kundu R., Wu L., Luo W., Ignelzi M.A., Snead M.L., Maxson R.E. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad. Sci. USA 1995, 92:6137-6141.
182. Liu Y.H., Tang Z., Kundu R.K., Wu L., Luo W., Zhu D., Sangiorgi F., Snead M.L., Maxson R.E. Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-media. Dev. Biol. 1999, 205:260-274.
183. Dodig M., Tadic T., Kronenberg M.S., Dacic S., Liu Y.H., Maxson R., Rowe D.W., Lichtler A.C. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev. Biol. 1999, 209:298-307.
184. Ryoo H.M., Hoffmann H.M., Beumer T., Frenkel B., Towler D.A., Stein G.S., Stein J.L., Van Wijnen A.J., Lian J.B. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol. Endocrinol. 1997, 11:1681-1694.
185. Newberry E.P., Latifi T., Towler D.A. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 1998, 37:16360-16368.
186. Acampora D., Merlo G.R., Paleari L., Zerega B., Postiglione M.P., Mantero S., Bober E., Barbieri O., Simeone A., Levi G. Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development 1999, 126:3795-3809.
187. Jochum W., David J.P., Elliott C., Wutz A., Plenk H., Matsuo K., Wagner E.F. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 2000, 6:980-984.
188. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E.J., Baron R. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adi-pogenesis. Nat. Med. 2000, 6:985-990.
189. Karsenty G. How many factors are required to remodel bone. Nat. Med. 2000, 6:970-971.
190. Aubin J.E. Your partner makes all the difference. IBMS-BoneKEy 2001, January 23, 10.1138/ibmske;2001013.
191. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., Shen J., Vinson C., Rueger J.M., Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000, 100:197-207.
192. Li B., Boast S., De Los Santos K., Schieren I., Quiroz M., Teitelbaum S.L., Tondravi M.M., Goff S.P. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nature Genet. 2000, 24:304-308.
193. Meyer T., Kneissel M., Mariani J., Fournier B. In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc. Natl. Acad. Sci. USA 2000, 97:9197-9202.
194. Bonnelye E., Merdad L., Kung V., Aubin J.E. The orphan nuclear estrogen receptor-related receptor alpha (ERRα) is differentially expressed during osteoblast differentiation and regulates bone formatio. J.Cell. Biol. 2001, 153:971-983.
195. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H., Glass D.A., Hartmann C., Li L., Hwang T.H., Brayton C.F., Lang R.A., Karsenty G., Chan L. Cbfal-independent decrease in osteoblast proliferation, osteo-penia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J.Cell. Biol. 2002, 157:303-314.
196. Gong Y., Slee R.B., Fukai N., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:423-513.
197. Little R.D., Carulli J.P., Del Mastro R.G., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 2002, 70:11-19.
198. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., Wu D., Insogna K., Lifton R.P. High bone density due to a mutation in LDL-receptor-related protein 5. N.Engl. J. Med. 2002, 346:1513-1521.
199. Patel M.S., Karsenty G. Regulation of bone formation and vision by LRP5. N.Engl. J. Med. 2002, 346:1572-1574.
200. Yang X., Karsenty G. Transcription factors in bone: Developmental and pathological aspects. Trends Mol. Med. 2002, 8:340-345.
201. Rodan G.A. Control of bone formation and resorption: Biological and clinical perspective. 25th anniversary issue: New directions and dimensions in cellular biochemistry. J.Cell. Bio-chem. Suppl. 1998, 30/31:55-61.
202. Khan S.N., Bostrom M.P., Lane J.M. Bone growth factors. Orthop. Clin. North Am. 2000, 31:375-388.
203. Gordon E.M., Skotzko M., Kundu R.K., Han B., Andrades J., Nimni M., Anderson W.F., Hall F.L. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for r. Hum. Gene Ther. 1997, 8:1385-1394.
204. Kuznetsov S.A., Friedenstein A.J., Robey P.G. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br. J. Haematol. 1997, 97:561-570.
205. Ellies L.G., Aubin J.E. Temporal sequence of interleukin lα-mediated stimulation and inhibition of bone formation by isolated fetal rat calvarial cells in vitro. Cytokine 1990, 2:430-437.
206. Antosz M.E., Bellows C.G., Aubin J.E. Biphasic effects of epidermal growth factor on bone nodule formation by isolated rat calvaria cells in vitro. J.Bone Miner. Res. 1987, 2:385-393.
207. Antosz M., Bellows C.G., Aubin J.E. Effects of transforming growth factor β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria c. J.Cell. Physiol. 1989, 140:386-395.
208. Breen E.C., Ignotz R., Mccabe L., Lian J.B., Stein G.S. TGFb alters growth and differentiation related gene expression in proliferating osteoblasts in vitro preventing development of the mature osteoblast phenotype. J.Cell. Physiol. 1994, 160:323-335.
209. Locklin R.M., Oreffo R.O., Triffitt J.T. Effects of TGFbeta and BFGF on the differentiation of human bone marrow stromal fibroblasts. Cell. Biol. Int. 1999, 23:185-194.
210. Hsieh S.C., Graves D.T. Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory. J.Cell. Biochem. 1998, 69:169-180.
211. Aubin J.E., Heersche J.N.M. Cellular actions of parathyroid hormone on osteoblast and osteoclast differentiation. The Parathyroids 2001, Academic Press, San Diego. 2nd ed. J.P. Bilezikian, R. Marcus, M. Levine (Eds.).
212. Bellows C.G., Ishida H., Aubin J.E., Heersche J.N.M. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 1990, 127:3111-3116.
213. Ishizuya T., Yokose S., Hori M., Noda T., Suda T., Yoshiki S., Yamaguchi A. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J.Clin. Invest. 1997, 99:2961-2970.
214. Karaplis A.C., Kronenberg H.M. Physiological roles for parathyroid hormone-related protein: Lessons from gene knockout mice. Vitamins Horm. 1996, 52:177-193.
215. Lanske B., Amling M., Neff L., Guiducci J., Baron R., Kronenberg H.M. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J.Clin. Invest. 1999, 104:399-407.
216. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone [see Comments]. J.Clin. Invest. 1999, 104:439-446.
217. Schipani E., Kruse K., Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995, 268:98-100.
218. Ducy P., Karsenty G. The family of bone morpho-genetic proteins. Kidney Int. 2000, 57:2207-2214.
219. Bonewald L.F. Transforming growth factorβ. Principles of Bone Biology 1996, 647-659. Academic Press, San Diego. J.P. Bilezikian, L.G. Raisz, G.A. Rodan (Eds.).
220. Erlebacher A., Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J.Cell. Biol. 1996, 132:195-210.
221. Erlebacher A., Filvaroff E.H., Ye J.Q., Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell. 1998, 9:1903-1918.
222. Filvaroff E., Erlebacher A., Ye J., Gitelman S.E., Lotz J., Heillman M., Derynck R. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 1999, 126:4267-4279.
223. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effect. J.Clin. Invest. 1998, 102:274-282.
224. Lukert B.P., Kream B.E. Clinical and basic aspects of glucocorticoid action in bone. Principles of Bone Biology 1996, 533-548. Academic Press, San Diego. J.P. Bilezikian, L.G. Riasz, G.A. Rodan (Eds.).
225. Malaval L., Gupta A.K., Liu F., Delmas P.D., Aubin J.E. LIF, but not IL-6, regulates osteoprogenitor differentiation: Modulation by dexamethasone. J.Bone Miner. Res. 1998, 13:175-184.
226. Boden S.D., Hair G., Titus L., Racine M., Mccuaig K., Wozney J.M., Nanes M.S. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 1997, 138:2820-2828.
227. Boden S.D., Liu Y., Hair G.A., Helms J.A., Hu D., Racine M., Nanes M.S., Titus L. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 1998, 139:5125-5134.
228. Yamada M., Suzu S., Tanaka-Douzono M., Wakimoto N., Hatake K., Hayasawa H., Motoyoshi K. Effect of cytokines on the proliferation/differentiation of stroma-initiating cells. J.Cell. Physiol. 2000, 184:351-355.
229. Van Der Plas A., Aarden E.M., Feijen J.H., De Boer A.H., Wiltink A., Alblas M.J., De Leij L., Nijweide P.J. Characteristics and properties of osteocytes in culture. J.Bone Miner. Res. 1994, 9:1697-1704.
230. Westbroek I., De Rooij K.E., Nijweide P.J. Osteo-cyte-specific monoclonal antibody MAb OB7.3 is directed against Phex protein. J.Bone Miner. Res. 2002, 17:845-853.
231. Aarden E.M., Wassenaar A.M., Alblas M.J., Nijweide P.J. Immunocytochemical demonstration of extracellular matrix proteins in isolated osteocytes. Histochem. Cell. Biol. 1996, 106:495-501.
232. Aarden E.M., Nijweide P.J., Van Der Plas A., Alblas M.J., Mackie E.J., Horton M.A., Helfrich M.H. Adhesive properties of isolated chick osteocytes in vitro. Bone 1996, 18:305-313.
233. Klein-Nulend J., Semeins C.M., Ajubi N.E., Nijweide P.J., Burger E.H. Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibro-blasts-Correlation with prostaglandin upregulation. Biochem. Biophys. Res. Commun. 1995, 217:640-648.
234. Westbroek I., Ajubi N.E., Alblas M.J., Semeins C.M., Klein-Nulend J., Burger E.H., Nijweide P.J. Differential stimulation of prostaglandin G/H synthase-2 in osteocytes and other osteogenic cells by pulsating fluid flow. Biochem. Biophys. Res. Commun. 2000, 268:414-419.
235. Kato Y., Windle J.J., Koop B.A., Mundy G.R., Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J.Bone Miner. Res. 1997, 12:2014-2023.
236. Bonewald L.F. Establishment and characterization of an osteocyte-like cell line, MLO-Y4. J.Bone Miner. Metab. 1999, 17:61-65.
237. Bord S., Horner A., Beavan S., Compston J. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J.Clin. Endocrinol. Metab. 2001, 86:2309-2314.
238. Braidman I.P., Hainey L., Batra G., Selby P.L., Saunders P.T., Hoyland J.A. Localization of estrogen receptor beta protein expression in adult human bone. J.Bone Miner. Res. 2001, 16:214-220.
239. Hughes D.E., Salter D.M., Simpson R. CD44 expression in human bone: A novel marker of osteocytic differentiation. J.Bone Miner. Res. 1994, 9:39-44.
240. Nakamura H., Kenmotsu S., Sakai H., Ozawa H. Localization of CD44, the hyaluronate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tissue Res. 1995, 280:225-233.
241. Nakamura H., Ozawa H. Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae. J.Bone Miner. Res. 1996, 11:1715-1722.
242. Noonan K.J., Stevens J.W., Tammi R., Tammi M., Hernandez J.A., Midura R.J. Spatial distribution of CD44 and hyaluronan in the proximal tibia of the growing rat. J.Orthop. Res. 1996, 14:573-581.
243. Lean J.M., Mackay A.G., Chow J.W., Chambers T.J. Osteocytic expression of mRNA for c-fos and IGF-I: An immediate early gene response to an osteogenic stimulus. Am. J. Physiol. 1996, 270:E937-E945.
244. Mason D.J., Hillam R.A., Skerry T.M. Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant a. J.Bone Miner. Res. 1996, 11:350-357.
245. Su M., Borke J.L., Donahue H.J., Li Z., Warshawsky N.M., Russell C.M., Lewis J.E. Expression of connexin 43 in rat mandibular bone and periodontal ligament (PDL) cells during experimental tooth movement. JDent. Res. 1997, 76:1357-1366.
246. Divieti P., Inomata N., Chapin K., Singh R., Juppner H., Bringhurst F.R. Receptors for the carboxyl-terminal region of pth(l-84) are highly expressed in osteocytic cells. Endocrinology 2001, 142:916-925.
247. Van Loon J.J.W.A., Veldhuijzen J.P., Burger E.H. Bone and space flight: An overview. Biological and Medical Research in Space 1996, 259-299. Springer, San Diego. D. Moore, P. Bie, H. Oser (Eds.).
248. Lanyon L.E. Using functional loading to influence bone mass and architecture: Objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process. Bone 1996, 18:37S-43S.
249. Huiskes R., Ruimerman R., Van Lenthe G.H., Janssen J.D. Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 2000, 405:704-706.
250. Burger E.H., Klein-Nulend J. Mechanotransduction in bone-Role of the lacuno-canalicular network. FASEB J. 1999, 13:S101-S112.
251. Basso N., Heersche J.N. Characteristics of in vitro osteoblastic cell loading models. Bone 2002, 30:347-351.
252. Burger E.H., Klein-Nulend J. Microgravity and bone cell mechanosensitivity. Bone 1998, 22:127S-130S.
253. Skerry T.M., Bitensky L., Chayen J., Lanyon L.E. Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J.Bone Miner. Res. 1989, 4:783-788.
254. Klein-Nulend J., van der Plas A., Semeins C.M., Ajubi N.E., Frangos J.A., Nijweide P.J., Burger E.H. Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J. 1995, 9:441-445.
255. Ajubi N.E., Klein-Nulend J., Nijweide P.J., Vrijheid-Lammers T., Alblas M.J., Burger E.H. Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes-A cytoskeleton-dependent process. Biochem. Biophys. Res. Commun. 1996, 225:62-68.
256. Schoenwaelder S.M., Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell. Biol. 1999, 11:274-286.
257. Carpenter C.L. Actin cytoskeleton and cell signaling. Crit. Care Med. 2000, 28:N94-N99.
258. Gerthoffer W.T., Gunst S.J. Invited review: Focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J.Appl. Physiol. 2001, 91:963-972.
259. Carvalho R.S., Scott J.E., Suga D.M., Yen E.H. Stimulation of signal transduction pathways in osteoblasts by mechanical strain potentiated by parathyroid hormone. J.Bone Miner. Res. 1994, 9:999-1011.
260. Chow J.W., Fox S., Jagger C.J., Chambers T.J. Role for parathyroid hormone in mechanical responsiveness of rat bone. Am. J. Physiol. 1998, 274:E146-E154.
261. Jagger C.J., Chow J.W., Chambers T.J. Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone. J.Clin. Invest. 1996, 98:2351-2357.
262. Skerry T.M. Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: The role of glutamate as a paracrine signaling. J.Bone Miner. Metab. 1999, 17:66-70.
263. Gross T.S., Srinivasan S., Liu C.C., Clemens T.L., Bain S.D. Noninvasive loading of the murine tibia: An in vivo model for the study of mechanotransduction. J.Bone Miner. Res. 2002, 17:493-501.
264. Watanuki M., Sakai A., Sakata T., Tsurukami H., Miwa M., Uchida Y., Watanabe K., Ikeda K., Nakamura T. Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading. J.Bone Miner. Res. 2002, 17:1015-1025.
265. Ishijima M., Rittling S.R., Yamashita T., Tsuji K., Kurosawa H., Nifuji A., Denhardt D.T., Noda M. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absenc. J.Exp. Med. 2001, 193:399-404.
266. Sakai A., Sakata T., Tanaka S., Okazaki R., Kunugita N., Norimura T., Nakamura T. Disruption of the p53 gene results in preserved trabecular bone mass and bone formation after mechanical unloading. J.Bone Miner. Res. 2002, 17:119-127.
267. Chenu C., Itzstein C., Espinosa L. Absence of evidence is not evidence of absence. Redundancy blocks determin-ation of cause and effect. J.Bone Miner. Res. 2001, 16:1728-1729. Discussion 1731-1732.
268. Skerry T., Genever P., Taylor A., Dobson K., Mason D., Suva L. Absence of evidence is not evidence of absence. The shortcomings of the GLAST knockout mouse. J.Bone Miner. Res. 2001, 16:1729-1730. Discussion 1731-1732.
269. Gray C., Marie H., Arora M., Tanaka K., Boyde A., Jones S., Attwell D. Glutamate does not play a major role in controlling bone growth. J.Bone Miner. Res. 2001, 16:742-749.
270. Jiang J.X., Cheng B. Mechanical stimulation of gap junctions in bone osteocytes is mediated by prostaglandin E2. Cell. Adhesion Commun. 2001, 8:283-288.
271. Cheng B., Kato Y., Zhao S., Luo J., Sprague E., Bonewald L.F., Jiang J.X. PGE(2) is essential for gap junction-mediated intercellular communication between osteocyte-like MLO-Y4 cells in response to mechanical strain. Endocrinology 2001, 142:3464-3473.
272. Cheng B., Zhao S., Luo J., Sprague E., Bonewald L.F., Jiang J.X. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J.Bone Miner. Res. 2001, 16:249-259.
273. Heino T.J., Hentunen T.A., Vaananen H.K. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: Enhancement by estrogen. J.Cell. Biochem. 2002, 85:185-197.
274. Maejima-Ikeda A., Aoki M., Tsuritani K., Kamioka K., Hiura K., Miyoshi T., Hara H., Takano-Yamamoto T., Kume-Gawa M. Chick osteocyte-derived protein inhibits osteoclastic bone resorption. Biochem. J. 1997, 322:245-250.
275. Nesbitt S.A., Horton M.A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997, 276:266-269.
276. Lakkakorpi P.T., Vaananen H.K. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J.Bone Miner. Res. 1991, 6:817-826.
277. Lakkakorpi P.T., Horton M.A., Helfrich M.H., Karhukorpi E.K., Vaananen H.K. Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J.Cell. Biol. 1991, 115:1179-1186.
278. Horton M.A. The alpha v beta 3 integrin "vitronectin receptor". Int. J. Biochem. Cell. Biol. 1997, 29:721-725.
279. Blair H.C., Teitelbaum S.L., Ghiselli R., Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989, 245:855-857.
280. Williams J.P., Mcdonald J.M., Mckenna M.A., Jordan S.E., Radding W., Blair H.C. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H (+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodieste. J.Cell. Biochem. 1997, 66:358-369.
281. Schlesinger P.H., Blair H.C., Teitelbaum S.L., Edwards J.C. Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption. J.Biol. Chem. 1997, 272:18636-18643.
282. Teti A., Blair H.C., Schlesinger P., Grano M., Zambonin-Zallone A., Kahn A.J., Teitelbaum S.L., Hruska K.A. Extracellular protons acidify osteoclasts, reduce cytosolic calcium, and promote expression of cell-matrix attachment structures. J.Clin. Invest. 1989, 84:773-780.
283. Everts V., Delaisse J.M., Korper W., Niehof A., Vaes G., Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J.Cell. Phy-siol. 1992, 150:221-231.
284. Bossard M.J., Tomaszek T.A., Thompson S.K., Amegadzie B.Y., Hanning C.R., Jones C., Kurdyla J.T., Mcnulty D.E., Drake F.H., Gowen M., Levy M.A. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J.Biol. Chem. 1996, 271:12517-12524.
285. Gelb B.D., Moissoglu K., Zhang J., Martignetti J.A., Bromme D., Desnick R.J. Cathepsin K: Isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. Biochem. Mol. Med. 1996, 59:200-206.
286. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., Moritz J.D., Schu P., Von Figura K. Impaired osteoclastic bone resorption leads to osteopetro-sis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 1998, 95:13453-13458.
287. Gowen M., Lazner F., Dodds R., Kapadia R., Feild J., Tavaria M., Bertoncello I., Drake F., Zavarselk S., Tellis I., Hertzog P., Debouck C., Kola I. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J.Bone Miner. Res. 1999, 14:1654-1663.
288. Atley L.M., Mort J.S., Lalumiere M., Eyre D.R. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope. Bone 2000, 26:241-247.
289. Delaisse J.M., Eeckhout Y., Sear C., Galloway A., Mccullagh K., Vaes G. A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem. Biophys. Res. Commun. 1985, 133:483-490.
290. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., Docherty A.J., Beertsen W. Functional heterogeneity of osteoclasts: Matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 1999, 13:1219-1230.
291. Zhao W., Byrne M.H., Boyce B.F., Krane S.M. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J.Clin. Invest. 1999, 103:517-524.
292. Everts V., Delaisse J.M., Korper W., Beertsen W. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J.Bone Miner. Res. 1998, 13:1420-1430.
293. Zhao H., Ettala O., Vaananen H.K. Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab pr. Biochem. Biophys. Res. Commun. 2002, 293:1060-1065.
294. Salo J., Lehenkari P., Mulari M., Metsikko K., Vaananen H.K. Removal of osteoclast bone resorption products by transcytosis. Science 1997, 276:270-273.
295. Gaillard P.J., Herrmann-Erlee M.P., Hekkelman J.W., Burger E.H., Nijweide P.J. Skeletal tissue in culture. Hormonal regulation of metabolism and development. Clin. Orthop. 1979, 196-214.
296. Gothlin G., Ericsson J.L. On the histogenesis of the cells in fracture callus. Electron microscopic autoradiographic observations in parabiotic rats and studies on labeled monocytes. Virchows Arch. B Cell. Pathol. 1973, 12:318-329.
297. Walker D.G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975, 190:784-785.
298. Scheven B.A., Visser J.W., Nijweide P.J. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986, 321:79-81.
299. Felix R., Hofstetter W., Cecchini M.G. Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur. J. Endocrinol. 1996, 134:143-156.
300. Weir E.C., Horowitz M.C., Baron R., Centrella M., Kacinski B.M., Insogna K.L. Macrophage colony-stimulating factor release and receptor expression in bone cells. J.Bone Miner. Res. 1993, 8:1507-1518.
301. Itoh K., Udagawa N., Matsuzaki K., Takami M., Amano H., Shinki T., Ueno Y., Takahashi N., Suda T. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP r. J.Bone Miner. Res. 2000, 15:1766-1775.
302. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A., Tsuda E., Morinaga T., Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998, 139:1329-1337.
303. Lacey D.L., Timms E., Tan H.L., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 391:315-323.
304. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
305. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H.L., Xu W., Lacey D.L., Boyle W.J., Simonet W.S. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998, 12:1260-1268.
306. Cappellen D., Luong-Nguyen N.H., Bongiovanni S., Grenet O., Wanke C., Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of. J.Biol. Chem. 2002, 277:21971-21982.
307. Matsuo K., Owens J.M., Tonko M., Elliott C., Chambers T.J., Wagner E.F. Fosll is a transcriptional target of c-Fos during osteoclast differentiation. Nature Genet. 2000, 24:184-187.
308. Collin-Osdoby P., Rothe L., Anderson F., Nelson M., Malo-Ney W., Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endo-thelial cells, regulation by inflammatory cytokines, and role in h. J.Biol Chem. 2001, 276:20659-20672.
309. Kasperk C.H., Borcsok I., Schairer H.U., Schneider U., Nawroth P.P., Niethard F.U., Ziegler R. Endothe-lin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif. Tissue Int. 1997, 60:368-374.
310. Nakagawa M., Kaneda T., Arakawa T., Morita S., Sato T., Yomada T., Hanada K., Kumegawa M., Hakeda Y. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 2000, 473:161-164.
311. Quinn J.M., Itoh K., Udagawa N., Hausler K., Yasuda H., Shima N., Mizuno A., Higashio K., Takahashi N., Suda T., Martin T.J., Gillespie M.T. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J.Bone Miner. Res. 2001, 16:1787-1794.
312. Itoh K., Udagawa N., Katagiri T., Iemura S., Ueno N., Yasuda H., Higashio K., Quinn J.M., Gillespie M.T., Martin T.J., Suda T., Takahashi N. Bone morpho-genetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001, 142:3656-3662.
313. Eriksen E.F., Mosekilde L. Estrogens and bone. Bone Miner. Res. 1990, 7:273-312.
314. Rassi C.M., Lieberherr M., Chaumaz G., Pointillart A., Cournot G. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J.Bone Miner. Res. 2002, 17:630-638.
315. Srivastava S., Toraldo G., Weitzmann M.N., Cenci S., Ross F.P., Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J.Biol. Chem. 2001, 276:8836-8840.
316. Lees R.L., Sabharwal V.K., Heersche J.N. Re-sorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films. Bone 2001, 28:187-194.
317. Vignery A., Wang F., Qian H.Y., Benz E.J., Gilmore-Hebert M. Detection of the Na(+)-K(+)-ATPase alpha 3-isoform in multinucleated macrophages. Am. J. Physiol. 1991, 260:F704-F709.
318. Enelow R.I., Sullivan G.W., Carper H.T., Mandell G.L. Cytokine-induced human multinucleated giant cells have enhanced candidacidal activity and oxidative capacity compared with macrophages. J.Infect. Dis. 1992, 166:664-668.
319. Woods C., Domenget C., Solari F., Gandrillon O., Lazarides E., Jurdic P. Antagonistic role of vitamin D3 and retinoic acid on the differentiation of chicken hematopoietic macrophages into osteoclast precursor cells. Endocrinology 1995, 136:85-95.
320. Taylor M.V. Muscle differentiation: How two cells become one. Curr. Biol. 2002, 12:R224-R228.
321. Lipschutz J.H., Mostov K.E. Exocytosis: The many masters of the exocyst. Curr. Biol. 2002, 12:R212-R214.
322. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
323. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., Stanley E.R. Total absence of colony-stimulating factor 1 in the macro-phage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 1990, 87:4828-4832.
324. Helfrich M.H., Gerritsen E.J. Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis. Br. J. Haematol. 2001, 112:64-68.
325. Tsuji T., Hughes F.J., McCulloch C.A., Melcher A.H. Effects of donor age on osteogenic cells of rat bone marrow in vitro. Mech. Ageing Dev. 1990, 51:121-132.
326. DTppolito G., Schiller P.C., Ricordi C., Roos B.A., Howard G.A. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J.Bone Miner. Res. 1999, 14:1115-1122.
327. Oreffo R.O., Bennett A., Carr A.J., Triffitt J.T. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand. J. Rheumatol. 1998, 27:415-424.
328. Oreffo R.O., Bord S., Triffitt J.T. Skeletal progenitor cells and ageing human populations. Clin. Sci. 1998, 94:549-555.
329. Nishida S., Endo N., Yamagiwa H., Tanizawa T., Takahashi H.E. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J.Bone Miner. Metab. 1999, 17:171-177.
330. Bergman R.J., Gazit D., Kahn A.J., Gruber H., Mcdougall S., Hahn T.J. Age-related changes in osteogenic stem cells in mice. J.Bone Miner. Res. 1996, 11:568-577.
331. Egrise D., Vienne A., Martin D., Schoutens A. Trabecular bone cell proliferation ex vivo increases with donor age in the rat: It is correlated with the extent of bone loss and not with histomorphometric i. Calcif. Tissue Int. 1996, 59:45-50.
332. Gazit D., Zilberman Y., Ebner R., Kahn A. Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-beta. J.Cell. Biochem. 1998, 70:478-488.
333. Pfeilschifter J., Diel I., Pilz U., Brunotte K., Naumann A., Ziegler R. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J.Bone Miner. Res. 1993, 8:707-717.
334. Erdmann J., Kogler C., Diel I., Ziegler R., Pfeilschifter J. Age-associated changes in the stimulatory effect of transforming growth factor beta on human osteogenic colony formation. Mech. Ageing Dev. 1999, 110:73-85.
335. Ankrom M.A., Patterson J.A., D'avis P.Y., Vetter U.K., Blackman M.R., Sponseller P.D., Tayback M., Robey P.G., Shapiro J.R., Fedarko N.S. Age-related changes in human oestrogen receptor alpha function and levels in osteo-blasts. Biochem. J. 1998, 333:787-794.
336. Fujieda M., Kiriu M., Mizuochi S., Hagiya K., Kaneki H., Ide H. Formation of mineralized bone nodules by rat calvarial osteoblasts decreases with donor age due to a reduction in signaling through EP(1) subtype of prostagla. J.Cell. Biochem. 1999, 75:215-225.
337. Riminucci M., Fisher L.W., Majolagbe A., Corsi A., Lala R., De Sanctis C., Robey P.G., Bianco P. A novel GNAS1 mutation, R201G, in McCune-Albright syndrome. J.Bone Miner. Res. 1999, 14:1987-1989.
338. Bianco P., Riminucci M., Majolagbe A., Kuznetsov S.A., Collins M.T., Mankani M.H., Corsi A., Bone H.G., Wien-Troub S., Spiegel A.M., Fisher L.W., Robey P.G. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J.Bone Miner. Res. 2000, 15:120-128.
339. Colman A., Kind A. Therapeutic cloning: Concepts and practicalities. Trends. Biotechnol. 2000, 18:192-196.
340. Prockop D.J. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy. J.Cell. Biochem. Suppl. 1998, 30/31:284-285.
341. McCarthy M. Bioengineers bring new slant to stem-cell research. Lancet 2000, 356:1500.
342. Service R.F. Tissue engineers build new bone. Science 2000, 289:1498-1500.
343. Weissman I.L. Translating stem and progenitor cell biology to the clinic: Barriers and opportunities. Science 2000, 287:1442-1446.
344. Triffitt J.T. Stem cells and the philosopher's stone. J.Cell. Biochem. Suppl. 2002, 38:13-19.
345. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrick L.A., Neel M.D., Mccarville M.E., Orchard P.J., Pyeritz R.E., Brenner M.K. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
346. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy. Proc. Natl. Acad. Sci. USA 2002, 99:8932-8937.
347. Pereira R.F., Halford K.W., O'Hara M.D., Leeper D.B., Sokolov B.P., Pollard M.D., Bagasra O., Prockop D.J. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA 1995, 92:4857-4861.
348. Nilsson S.K., Dooner M.S., Weier H.U., Frenkel B., Lian J.B., Stein G.S., Quesenberry P.J. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J.Exp. Med. 1999, 189:729-734.